Over Rs. 65 billion disbursed among 7.2 million beneficiaries under Benazir Kafaalat
ISLAMABAD, Jul 12 (APP): Benazir Income Support Programme (BISP) has disbursed more than Rs. 65 billion among over 7.2 million beneficiary women so far.
BISP is disbursing the 4th quarterly tranche of Benazir Kafaalat for the Financial Year-2022-23.
Under Benazir Kafaalat, nine million registered beneficiary families are entitled to a quarterly installment of Rs 9,000 per household.
BISP has already released over Rs 81 billion to its partner banks, that is, Bank Alfalah and Habib Bank Limited (HBL) for disbursement among the beneficiaries through their retail distribution network.
Along with Benazir Kafaalat, Benazir educational scholarships are also being given out to the children of registered families, however, 70% attendance in the school is mandatory to receive educational scholarships, said the spokesman of the programme.
In case of any complaint, beneficiaries can approach the nearest BISP Tehsil Offices or call on toll-free helpline number 080026477 of Benazir Income Support Program.
The BISP spokesman reiterated that any messages from Benazir Income Support Program is sent only from 8171 and message from any other number should not be trusted
Railway staffers of Anti-Encroachment Cell demolishing encroachments at Makki Shah area
A view of open manhole on the road of Al Abbas Chowk
PPMA delegation calls on Chairman FBR, discuss sale tax regime
ISLAMABAD, Jul 12 (APP): A delegation of Pakistan Pharmaceutical Manufacturers Association (PPMA) Wednesday called on the Chairman Federal Board of Revenue (FBR) Asim Ahmad and discussed issues related to sale tax regime governing the pharma sector.
The delegation was led by Chairman PPMA Syed Farooq Bukhari including members as well as ex Chairman of the Association, said a press release.
The meeting was also attended by Member IR-Policy FBR Afaq Ahmad Qureshi.
The delegation invited Chairman FBR to attend the Pharma Export Seminar on July 12 and several other operational issues were also discussed during the meeting.
The chairman assured the delegation of all possible support for resolution of issues being faced by the Pharma industry.